Cargando…
lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p
BACKGROUND: Dysregulation of ACTA2-AS1 and miR-532-5p and their functions in various cancers have been widely reported. Their potential of serving as biomarkers in triple-negative breast cancer (TNBC) remains unknown. This study aimed to evaluate the function of ACTA2-AS1 and miR-532-5p and their po...
Autores principales: | Peng, Yi, Huang, Xiaoxi, Wang, Hongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327331/ https://www.ncbi.nlm.nih.gov/pubmed/35896973 http://dx.doi.org/10.1186/s12860-022-00432-7 |
Ejemplares similares
-
lncRNA DARS-AS1 Promoted Osteosarcoma Progression through Regulating miR-532-3p/CCR7
por: Xue, Yan, et al.
Publicado: (2022) -
Overexpression of MiR-146a-5p Upregulates lncRNA HOTAIR in Triple-Negative Breast Cancer Cells and Predicts Poor Prognosis
por: Liang, Hongguang, et al.
Publicado: (2019) -
lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells
por: Liu, Zhiping, et al.
Publicado: (2022) -
LncRNA ACTA2-AS1 suppress colon adenocarcinoma progression by sponging miR-4428 upregulation BCL2L11
por: Pan, Qingyun, et al.
Publicado: (2021) -
LncRNA PAPAS may promote triple-negative breast cancer by downregulating miR-34a
por: Kong, Yan, et al.
Publicado: (2019)